imatinib mesylate has been researched along with Peritonitis, Tuberculous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovacsovics, T; Meylan, P; Senn, L; Tarr, PE | 1 |
1 other study(ies) available for imatinib mesylate and Peritonitis, Tuberculous
| Article | Year |
|---|---|
Peritoneal tuberculosis after imatinib therapy.
Topics: Adult; Antineoplastic Agents; Antitubercular Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphopenia; Male; Opportunistic Infections; Peritonitis; Peritonitis, Tuberculous; Piperazines; Pyrimidines | 2009 |